{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:21:19Z","timestamp":1648934479174},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00120-009-1991-7","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T10:10:23Z","timestamp":1245924623000},"page":"619-624","source":"Crossref","is-referenced-by-count":1,"title":["Uringebundene Diagnostik"],"prefix":"10.1007","volume":"48","author":[{"given":"S.","family":"Hautmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.B.L.","family":"Lokeshwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.P.","family":"Juenemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,7]]},"reference":[{"key":"1991_CR1","first-page":"219","volume":"25","author":"Amling","year":"2000","unstructured":"Amling CL (2000) Diagnosis and management of superficial bladder cancer. Curr Probl Cancer 25:219\u2013278","journal-title":"Curr Probl Cancer"},{"key":"1991_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO;2-N","volume":"87","author":"Bastacky","year":"1999","unstructured":"Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM (1999) The accuracy of urinary cytology in daily practice. Cancer 87:118\u2013128","journal-title":"Cancer"},{"key":"1991_CR3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","volume":"21","author":"Botteman","year":"2003","unstructured":"Botteman MF, Pashos CL, Redaelli A et al (2003) The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 21:1315\u20131330","journal-title":"Pharmacoeconomics"},{"key":"1991_CR4","first-page":"203","volume":"84","author":"Datta","year":"2002","unstructured":"Datta SN, Allen GM, Evans R et al (2002) Urinary tract ultrasonography in the evaluation of haematuria \u2013 a report over 1.000 cases. Ann R Coll Surg Engl 84:203\u2013205","journal-title":"Ann R Coll Surg Engl"},{"key":"1991_CR5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00005392-200102000-00096","volume":"165","author":"Droller","year":"2001","unstructured":"Droller MJ (2001) Cancer heterogencity and its biologic implications in the grading of urothelial carcinoma. J Urol 165:696\u2013697","journal-title":"J Urol"},{"key":"1991_CR6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2004.06.006","volume":"46","author":"Hautmann","year":"2004","unstructured":"Hautmann SH, Toma M, Lorenzo Gomez MF et al (2004) Immunocyt an the HA-HAase urine tests for the detection of bladder cancer: a side by side comparison. Eur Urol 46:466\u2013471","journal-title":"Eur Urol"},{"key":"1991_CR7","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00120-007-1562-8","volume":"46","author":"Hautmann","year":"2007","unstructured":"Hautmann S, Eggers J, Meyhoff H et al (2007) Tumor markers for bladder cancer: Up to date study by the Kiel tumor bank. Urologe 46(11):1508\u20131513","journal-title":"Urologe"},{"key":"1991_CR8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1349-7006.1990.tb02677.x","volume":"81","author":"Kotake","year":"1990","unstructured":"Kotake T, Saiki S, Kinouchi T et al (1990) Detection of the c-myc gene product in urinary bladder cancer. Jpn J Cancer Res 81:1198\u20131201","journal-title":"Jpn J Cancer Res"},{"key":"1991_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0094-0143(05)70229-9","volume":"27","author":"Lee","year":"2000","unstructured":"Lee R, Droller MJ (2000) The natural history of bladder cancer. Implications for therapy. Urol Clin North Am 27:1\u201313","journal-title":"Urol Clin North Am"},{"key":"1991_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0094-0143(05)70239-1","volume":"27","author":"Liu","year":"2000","unstructured":"Liu BC, Loughlin KR (2000) Telomerase in human bladder cancer. Urol Clin North Am 27:115\u2013123","journal-title":"Urol Clin North Am"},{"key":"1991_CR11","unstructured":"Lokeshwar VB, Habuchi T, Grossman HB et al (2006) Cytology and tumor markers: Markers beyond cytology. In: Soloway MS (ed) Bladder Tumors, 21 edn. Health publications limited, Paris France, pp 65\u2013138"},{"key":"1991_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","volume":"61","author":"Lotan","year":"2003","unstructured":"Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. J Urol 61:109\u2013118","journal-title":"J Urol"},{"key":"1991_CR13","first-page":"2615","volume":"19","author":"Mahnert","year":"1999","unstructured":"Mahnert B, Tauber S, Kriegmair M et al (1999) BTA-TRAK \u2013 a useful diagnostic tool in urinary bladder cancer? Anticancer Res 19:2615\u20132619","journal-title":"Anticancer Res"},{"key":"1991_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0094-0143(05)70235-4","volume":"27","author":"Malkowicz","year":"2000","unstructured":"Malkowicz SB (2000) The application of human complement factor H-related protein (BTA-TRAK) in monitoring patients with bladder cancer. Urol Clin North Am 27:63\u201373 ix","journal-title":"Urol Clin North Am"},{"key":"1991_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/172460080001500303","volume":"15","author":"Mattioli","year":"2000","unstructured":"Mattioli S, Seregni E, Caperna L et al (2000) BTA-TRAK combined with urinary cytology is a reliable urinary indicator of recurrent transitinonal cell carcinoma (TCC) of the bladder. Int J Biol Markers 15:219\u2013225","journal-title":"Int J Biol Markers"},{"key":"1991_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-5347(05)66080-6","volume":"166","author":"Ponsky","year":"2001","unstructured":"Ponsky LE, Sharma S, Pandrangi L et al (2001) Screening and monitoring for bladder cancer: refining the use of NMP22. J Urol 166:75\u201378","journal-title":"J Urol"},{"key":"1991_CR17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-0142(20010815)92:4<768::AID-CNCR1381>3.0.CO;2-C","volume":"92","author":"van","year":"2001","unstructured":"van Rhijn BW, Lurkin I, Kirkels WJ et al (2001) Microsatellite analysis \u2013 DNA test in urine competes with cystoskopy in follow-up of superficial bladder carcinoma: a phase II trial. Cancer 92:768\u2013775","journal-title":"Cancer"},{"key":"1991_CR18","unstructured":"Ries LAG, Eisner MP, Kosary CL et al (eds) SEER Cancer Statistics Review. 1975\u20132001. Natl Canc Inst Bethesda, Maryland"},{"key":"1991_CR19","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1373\/clinchem.2004.032003","volume":"50","author":"Schultz","year":"2004","unstructured":"Schultz IJ, Kiemeney LA, Karthaus HF et al (2004) Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 50:1425\u20131428","journal-title":"Clin Chem"},{"key":"1991_CR20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00042307-200109000-00009","volume":"11","author":"van","year":"2001","unstructured":"van der Poel HG, Debruyne FM (2001) Can biological markers replace cystoscopy?. An update. Curr Opin Urol 11:503\u2013509","journal-title":"Curr Opin Urol"},{"key":"1991_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/dc.10291","volume":"28","author":"Veeramachaneni","year":"2003","unstructured":"Veeramachaneni R, Nordberg ML, Shi R et al (2003) Evaluation of flourescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 28:301\u2013307","journal-title":"Diagn Cytopathol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-009-1991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-009-1991-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-009-1991-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:48:05Z","timestamp":1558626485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-009-1991-7"}},"subtitle":["Ein Update der Kieler Tumorbank"],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1007\/s00120-009-1991-7","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}